Vaccines for Human Medicine
Código 300220 (Harmonized System 2012 by 6 digits)
2022: US$257M, Total Trade Exchange
2022: US$8.67M, International Sales
2022: US$248M, International Purchases
In 2022, the trade exchange (includes international purchases and sales) of Vaccines for Human Medicine was US$257M.
In 2022, the states with the most international sales in Vaccines for Human Medicine were Ciudad de México (US$8.66M).
The states with the most international purchases in 2022 were Ciudad de México (US$138M) and Estado de México (US$111M).
In 2022, the main commercial destinations of Vaccines for Human Medicine were Peru (US$4.89M), Guatemala (US$1.54M), Ecuador (US$886k), Chile (US$486k), and Venezuela (US$313k).
The main commercial origins of Vaccines for Human Medicine in 2022 were France (US$83.7M), United States (US$65.5M), Ireland (US$58M), Canada (US$17M), and Belgium (US$16.5M).
In the global context, the main exporting countries of Vaccines for Human Medicine in 2022 were Belgium (US$33.4B), Ireland (US$13.2B), and United States (US$8.76B). In the same year, the main importing countries of Vaccines for Human Medicine were Belgium (US$12.3B), Germany (US$10.8B), and United States (US$9.29B).
Trade Balance of Mexico
#permalink to sectionNet Trade Balance
#permalink to sectionUS$257M, Total Trade Exchange (2022)
In 2022, the total trade exchange of Vaccines for Human Medicine in Mexico (including international purchases and sales) was US$257M.
The visualizations show the net balance of Vaccines for Human Medicine at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
Net International Trade
#permalink to sectionDecember, 2022: US$20.6M, International Purchases
In December 2022, international sales of Vaccines for Human Medicine were US$0, while international purchases reached US$20.6M. The above results in a trade balance of -US$20.6M.
Exchange by Territory
#permalink to sectionInternational Sales
#permalink to sectionCiudad de México: US$8.66M, State with the Most International Sales (2022)
Peru: US$4.89M, Main commercial destination (2022)
In 2022, the states with the highest international sales in Vaccines for Human Medicine were Ciudad de México (US$8.66M).
In 2022, the countries with the most international purchases from Mexico were Peru (US$4.89M), Guatemala (US$1.54M), Ecuador (US$886k), Chile (US$486k), and Venezuela (US$313k).
International Purchases
#permalink to sectionCiudad de México: US$138M, State with the Most International Purchases (2022)
France: US$83.7M, Main Commercial Origin (2022)
In 2022, the states with the highest international in Vaccines for Human Medicine were Ciudad de México (US$138M) and Estado de México (US$111M).
The countries with the most international sales to Mexico in 2022 were France (US$83.7M), United States (US$65.5M), Ireland (US$58M), Canada (US$17M), and Belgium (US$16.5M).
Specialization
#permalink to sectionSpecialization by State
#permalink to sectionThe RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Vaccines for Human Medicine and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Vaccines for Human Medicine. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
Global Market
#permalink to sectionOrigins and Trade Destinations
#permalink to section- 0.091%, Mexican share in global exports - 2022
- 0.48%, Mexican share in global imports - 2022
The visualizations show the global market for Vaccines for Human Medicine. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Vaccines for Human Medicine were Belgium (US$33.4B), Ireland (US$13.2B), and United States (US$8.76B). In the same year, the main importing countries for Vaccines for Human Medicine were Belgium (US$12.3B), Germany (US$10.8B), and United States (US$9.29B).